Internal AOAC-style validation results for the SpectacularOne E. coli O157 Detection System. Built for enterprise scale. Backed by lab-grade performance.
The SpectacularOne system is currently undergoing AOAC PTM validation (Est. Q1 2026).
The results shown below are from internal AOAC-style performance studies conducted to showcase how our system was evaluated.
Once peer-reviewed publications become available, they will be displayed here.
The SpectacularOne E. coli O157 Detection System was evaluated using internal AOAC-style validation protocols across inclusivity, exclusivity, time-to-result (TTR), and surface detection limits.
This page summarizes our internal showcase study, including cross-reactivity with non-targets (Citrobacter and Salmonella), stainless steel surface testing, and amplification reproducibility.
Amplification behavior of E. coli O157 samples versus non-O157 controls (Citrobacter, Salmonella). Negative controls remain flat, validating exclusivity.
The SpectacularOne SDS demonstrated internal AOAC-style performance with 100% inclusivity, 100% exclusivity, rapid TTR, and successful surface-level detection of E. coli O157.
To receive the full technical documentation, including method development and amplification conditions, contact our biology team directly.